Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.

Researchers reevaluated the use of opioid prescriptions in an acute palliative care unit among patients with advanced cancer.

The risk of mortality for patients with colon cancer is significantly higher for those with cannabis-use disorder, compared with use disorders of other substances.

Higher education linked to higher AI acceptance; concern for bias greater in Hispanic, non-Hispanic Black versus White participants.

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.